Sanofi proposes a diversified offer of prescription medicines, consumer healthcare products, generic drugs, vaccines and animal health products. With the new Genzyme, Sanofi can now address the needs of patients with rare diseases and multiple sclerosis.
Sanofi produces 5 billion boxes of medicines per year. How can the quality of each of them be guaranteed? What is the place of innovation in the industrial production? What is biotechnology?
Philippe Luscan, Executive Vice-President Global Industrial Affairs, answers these questions in the video “FROM PLANT TO PATIENT : A MEDICINE’S JOURNEY”.